Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
PhRMA's lawsuit is the fourth legal challenge to the law after separate suits from Merck, Bristol Myers Squibb and the
Read More
Eli Lilly and Co
Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push
Dice is a biopharmaceutical company that uses a proprietary technology platform to develop new oral therapeutic drugs for autoimmune diseases.
Read More
Eli Lilly CEO says Medicare price negotiations could harm drug development
The CEO said the "biggest problem" with the Inflation Reduction Act provision stems from a difference in timeline for negotiating
Read More
UBS names its top-conviction picks for the rest of 2023
Here are some of the stocks UBS analysts think will outperform amid an uncertain market environment. Source link
Read More
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
CAR-T immunotherapies and antibody drug conjugates will highlight the American Society of Clinical Oncology's cancer research conference that starts Thursday.
Read More
Here are Wednesday’s biggest analyst calls: Tesla, Amazon, Alphabet, Netflix, Apple, Eli Lilly & more
Here are the biggest calls on Wall Street on Source link
Read More
Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
The authors said the estimated cost of Leqembi to Medicare are conservative, and spending on the Alzheimer's treatment may increase
Read More
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of
Read More
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day. Source link
Read More